A case of progressive systemic sclerosis (CREST syndrome), which began in childhood, is described. Juvenile onset CREST syndrome is extremely rare; there are few well documented cases and no published series of children with this form of progressive systemic sclerosis. An anticentromere antibody was recently detected in this case and its significance is discussed.
Case report
The patient first presented to the dermatology department in 1970, at the age of 12 years. He had suffered from severe Raynaud's phenomenon since the age of 6, and for several years subcutaneous calcification had been noted on the fingers and around the knees (Figure 1 ). There were no telangiectasiae but dilated nail-fold capillaries were present (Figure 2 ). A barium swallow demonstrated disordered oesophageal function with delayed emptying. The diagnosis of early CREST syndrome was made. Two years later he developed telangiectasiae on the left eyelid.
In March 1972 he was presented to a meeting of the Section of Dermatology of the Royal Society of Medicine (unpublished), the diagnosis then being systemic sclerosis.
The amount of telangiectasia has gradually increased; however, the Raynaud's phenomenon has slowly improved. He is now 25 years old. He continues to have problems from subcutaneous calcification with extrusion of calcium mainly around the knees and fingers. Sclerodactyly is present with a mild fixed flexion deformity of the interphalangeal joints in the right index, right middle, right ring and left middle fingers. There is pulp atrophy (Figure 3 ). He has many telangiectasiae on normal skin over the face, chest and back. Dysphagia is an intermittent problem.
Examination is otherwise normal. Electrocardiogram, lung function testing, routine haematological, biochemical and urine screens are normal. Screening for antinuclear factor using an organ substrate was repeatedly negative. 1Case presented to the Section of Dermatology, 19 January 1984. Accepted 27 April 1984 However, in 1983 a serum anticentromere antibody was demonstrated using tissue culture cells (HEP-2) as the -substrate. There is no rheumatoid factor or antimitochondrial factor.
Discussion
Progressive systemic sclerosis is extremely rare in childhood. There are no published series of children with the CREST syndrome. Several recent studies have reviewed scleroderma in childhood (Jaffe & Winkelmann 1961; Cassidy et al. 1977 ). Raynaud's phenomenon is frequently a presenting symptom but may improve with age. Cutaneous manifestations are generally slowly progressive and joint contractures are a frequent complication. Calcinosis is uncommon in children with scleroderma, as it tends to be a late feature of the disease, occurring on average 11 years after onset. It is commoner in females and associated with severe acrosclerosis (Muller et al. 1959) .
Children with widely differing forms of the disease have been grouped together by many authorities attempting to reach prognostic conclusions; the results are based on small numbers and are therefore variable. Patterns of cutaneous and visceral involvement in children and adults are similar, and in general the disease is slowly progressive. Cardiac and pulmonary disease are primarily responsible for morbidity and mortality (Cassidy et al. .1977) .
The CREST syndrome is not well documented in children. There are individuals in the published series of children with scleroderma that may fit into this subgroup (Jaffe & Winkelmann 1961 , Cassidy et al. 1977 , but there are no long-term follow-up studies separating these children from those with other forms of progressive systemic sclerosis. The CREST syndrome is much more common in females. This form of systemic sclerosis tends to pursue a slowly progressive course. Severe renal or myocardial involvement is rare. However, there is a risk of serious complications even 30 years after the development of Raynaud's phenomenon (Rodnan et al. 1975 ). Severe pulmonary hypertension may develop, leading to progressive cor pulmonale and death. Pulmonary fibrosis may be minimal or absent.
Numerous antinuclear antibodies have been described in systemic sclerosis. The incidence depends on the substrate used. Routine testing for antinuclear factor on an organ substrate may be 'negative', but use of a more sensitive tissue culture cell substrate will increase the likelihood of detecting cellular antibodies. Recent studies have shown that the CREST syndrome can be separated serologically from other forms of scleroderma by its frequent association with anticentromere antibodies. The antibody was found in 26 of 27 patients with CREST syndrome, 3 of 14 patients with Raynaud's phenomenon, 3 of 26 patients with systemic sclerosis and 1 of 60 patients with systemic lupus erythematosus (Fritzler & Kinsella 1980 , Tuffanelli et al. 1983 . The presence of this antibody seems to justify the clinical separation of the CREST syndrome from other forms of systemic sclerosis. Male patients with progressive systemic sclerosis generally have a poor prognosis, but we believe that this man has a form of progressive systemic sclerosis which is slowly progressive with a prolonged delay in appearance of visceral changes. The significance of the anticentromere antibody is unknown. It may merely be an epiphenomenon, but perhaps it is more closely related to disease pathogenesis, implying disease activity. We report a patient who developed penicillamine dermopathy following high-dose D-penicillamine therapy for cystinuria, and in whom pseudoxanthoma elasticum-like skin changes subsequently developed; this does not appear to have been reported previously.
--

Case report
The patient, a 59-year-old man, was diagnosed as having cystinuria at the age of 37 years; the diagnosis was based upon the history of many episodes of renal colic, the presence of multiple renal calculi on X-ray, the spontaneous passage of a urinary calculus composed of almost pure cystine and elevated urinary cystine excretion 'Case presented to Section of Dermatology, 16 June
